By Mill Chart
Last update: Oct 4, 2022
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Ticker | Change | Comment |
---|---|---|
EJH | 2.0K% | E-HOME HOUSEHOLD SERVICE's (NASDAQ:EJH) stock price increased by 2.0K% to $1.83. In the last month the stock lost 50.58%. |
BTB | 175.0% | BIT BROTHER LTD (NASDAQ:BTB) rose 175.0% to $0.31 during Tuesday's after hours session. Shareholders saw the stock price going 32.1% lower in the past month. |
TOPS | 79.2% | TOP SHIPS INC's (NASDAQ:TOPS) stock price increased by 79.2% to $5.86. Shareholders saw the stock price going 42.53% lower in the past month. |
AERC | 75.07% | AEROCLEAN TECHNOLOGIES INC's (NASDAQ:AERC) stock price is advancing with 75.07% to a price of $5.62. Earlier today the company had a press release: BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Poshmark, Inc. (Nasdaq – POSH), First Eagle Alternative Capital BDC, Inc. (Nasdaq – FCRD), AeroClean Technologies (Nasdaq – AERC), Talos Energy Inc. (NYSE - TALO). |
CNXA | 72.35% | CONNEXA SPORTS TECHNOLOGIES's (NASDAQ:CNXA) stock price is advancing with 72.35% to a price of $0.5. In the last month the stock lost 68.64%. |
ADVWW | 63.49% | ADVANTAGE SOLUTIONS IN-CW25 (NASDAQ:ADVWW) rose 63.49% to $0.18 during Tuesday's after hours session. In the last month the share price dropped with 71.77%. |
SNTI | 57.6% | SENTI BIOSCIENCES INC's (NASDAQ:SNTI) stock price is advancing with 57.6% to a price of $3.94. In the last month the stock gained 26.9%. |
INBX | 46.18% | INHIBRX INC's (NASDAQ:INBX) shares rose 46.18% to $29.5. The stock is trading 24.88% higher than a month ago. |
PEGY | 42.5% | PINEAPPLE ENERGY INC's (NASDAQ:PEGY) shares rose 42.5% to $1.14 during Tuesday's session. In the last month the stock lost 64.07%. |
APDN | 33.52% | APPLIED DNA SCIENCES INC's (NASDAQ:APDN) stock price is advancing with 33.52% to a price of $1.5. In the last month the stock lost 59.57%. |
Our top gainers screener will show you the full list.
Ticker | Change | Comment |
---|---|---|
ASZ.W | -99.75% | AUSTERLITZ ACQ CL A -CW27's (NYSE:ASZ.W) stock price decreased by 99.75% to $0.0. In the last 3 months the share price dropped with 38.65%. |
KALV | -57.51% | KALVISTA PHARMACEUTICALS INC's (NASDAQ:KALV) shares fell 57.51% to $6.05 during Tuesday's session. Yesterday the company had a press release: KalVista Pharmaceuticals Announces Termination of KVD824 Phase 2 KOMPLETE Trial for Prophylactic Treatment of Hereditary Angioedema. |
OBLG | -38.4% | OBLONG INC's (NASDAQ:OBLG) shares fell 38.4% to $0.25. The stock is trading 54.14% higher than a month ago. |
FNHC | -37.02% | FEDNAT HOLDING CO's (NASDAQ:FNHC) stock price is declining with 37.02% to a price of $0.3. The stock is trading 56.67% higher than a month ago. |
FAZE | -36.93% | FAZE HOLDINGS INC's (NASDAQ:FAZE) stock price decreased by 36.93% to $5.14. In the last month the share price dropped with 53.24%. |
VSTM | -33.65% | VERASTEM INC's (NASDAQ:VSTM) shares fell 33.65% to $0.58. A press release (Verastem Oncology Announces RAMP VS-6766 Clinical Trials and Corporate Updates) was released yesterday. |
CRH.W | -28.08% | COHN ROBBINS HOLDINGS -CW25's (NYSE:CRH.W) stock price decreased by 28.08% to $0.02. The stock is trading 96.76% lower than a month ago. |
BOA.W | -27.27% | BOA ACQUISITION CL A -CW28's (NYSE:BOA.W) stock price is declining with 27.27% to a price of $0.08. Shareholders saw the stock price going 85.67% higher in the past month. |
TBLTW | -26.71% | TOUGHBUILT INDUSTRIES-CW23's (NASDAQ:TBLTW) shares fell 26.71% to $0.12. In the last 3 months the stock gained 47.43%. |
BLEUR | -20.7% | BLUEACACIA LTD - RIGHTS's (NASDAQ:BLEUR) stock price decreased by 20.7% to $0.08. The stock is trading 22.27% lower than 3 months ago. |
To see the full list of top losers you can use our top losers screener.
SENTI BIOSCIENCES INC
NASDAQ:SNTI (5/1/2024, 4:28:25 PM)
After market: 0.38 0 (0%)0.38
+0.02 (+5.56%)
Senti Bio today announced the publication of preclinical data that supports the design of the Phase 1 clinical trial of SENTI-202....
SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Senti Biosciences (NASDAQ:SNTI) just reported results for the fourth quarter of...
– IND for SENTI-202, a potential first-in-class logic-gated treatment for AML, cleared by the U.S. FDA; First patient dosing anticipated in the second...
Senti Biosciences plans to cut workforce by ~37% to prioritize investment in its cell therapy for acute myeloid leukemia, SENTI-202.
– Strategic resource allocation to focus investment on clinical development of SENTI-202 and SENTI-301A partnership in China; interim data from Phase 1...
– First patient in Phase 1 clinical trial expected to be treated in Q2 2024 – – Initial clinical efficacy data expected by year-end 2024 and durability...
Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!